International Stem Cell Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares International Stem Cell with three other
companies in this sector in UNITED STATES :
China Pharma Holdings, Inc.
sales of $10.92 million
ProPhase Labs Inc
Albireo Pharma Inc
of which 100%
was Pharmaceutical Indust).
International Stem Cell reported sales of $9.47 million
December of 2019.
decrease of 14.6%
versus 2018, when the company's sales were $11.09 million.